Document is current
Any future updates will be listed below
-
Authors
Chen, Timothy L.
Harrington, Bonnie
Truxall, Jean
Wasmuth, Ronni
Prouty, Alexander
Sloan, Shelby
Lehman, Amy M.
Sampath, Deepa
Orlemans, Eric
Baiocchi, Robert A.
Alinari, Lapo
Byrd, John C.
Woyach, Jennifer A.
Hertlein, Erin https://orcid.org/0000-0001-8493-5679
-
Funding
Funding for this research was provided by:
National Cancer Institute (R35 CA197734-01, P01 CA81534, K12 CA133250, P30 CA016058)
Sullivan Foundation
Leukemia and Lymphoma Society (3077-12)
D. Warren Brown Family Foundation
- License Information
-
More Information
Article History
Received: 7 October 2020
Accepted: 28 January 2021
First Online: 24 February 2021
Ethics approval and consent to participate
: The authors are grateful to the patients who generously provided blood for these studies. Blood from CLL patients was obtained from the Ohio State University Leukemia Tissue Bank after obtaining informed consent approved by the cancer institution review board (IRB). All mouse protocols were reviewed and approved by The Ohio State University Institutional Animal Care and Use Committee (IACUC).
: Not applicable.
: At the time these studies were completed, E.O held the position of chief scientific officer for Esanex who provided SNX-2112 and SNX-5422 for this work.
